Procaps Group (NASDAQ: PROC), a leading integrated international healthcare and pharmaceutical company, today announced its financial results for the third quarter ended September 30, 2021.
Procaps Group, a leading integrated international healthcare and pharmaceutical company, and Union Acquisition Corp. II (NASDAQ: LATN, LATNU, LATNW) ("LATN"), a publicly-traded special purpose acquisition...
Union Acquisition Corp. II (NASDAQ: LATN, LATNU, LATNW) (“LATN”), a publicly-traded special purpose acquisition company, announced today that its shareholders voted to approve the previously announced...
Procaps Group (as defined below), a leading integrated international healthcare and pharmaceutical company, today announced that it has launched a private offering of an aggregate principal amount of U.S....
Procaps Group, a leading integrated international healthcare and pharmaceutical company, and Union Acquisition Corp. II (NASDAQ: LATN, LATNU, LATNW) ("LATN"), a publicly-traded special purpose acquisition...
Procaps Group, a leading integrated international healthcare and pharmaceutical company, announced that in conjunction with Procaps Group’s recent virtual analyst day and second quarter 2021 earnings...
Procaps Group, a leading integrated international healthcare and pharmaceutical company, has appointed Patricio Vargas as global Chief Financial Officer.
Procaps Group, a leading integrated international healthcare and pharmaceutical company, today announced its financial results for the second quarter ended June 30, 2021.
Procaps Group, a leading integrated international healthcare and pharmaceutical company and Union Acquisition Corp. II (NASDAQ: LATN, LATNU, LATNW) (“LATN”), a publicly-traded special purpose acquisition...
Procaps Group, a leading integrated international healthcare and pharmaceutical company, today provided preliminary estimates of its second quarter 2021 net revenues for the three months ended June 30,...